Skip to main content
OpenTrials

Clinical trial condition

Cytomegalovirus Infection

Explore clinical trials studying Cytomegalovirus Infection. Study availability and eligibility vary by location and protocol.

44 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Cytomegalovirus Infection trial results

Completed

Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing Loss

NCT01649869

Conditions
Cytomegalovirus Infection, Cytomegalovirus Infections, DNA Virus Infections, +12 more
Locations
  • Children's of Alabama Child Health Research Unit (CHRU) Birmingham, Alabama, United States
  • Children's National Medical Center - Sheikh Zayed Campus - Infectious Disease Washington D.C., District of Columbia, United States
  • Washington University School of Medicine in St. Louis - Center for Clinical Studies St Louis, Missouri, United States
  • Steven and Alexandra Cohen Childrens Medical Center of New York - New Hyde Park - Infectious Disease Manhasset, New York, United States
View all 18 locations
View Trial Details
Completed

Extension of Letermovir (LET) From Day 100 to Day 200 Post-transplant for the Prevention of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant (HSCT) Participants (MK-8228-040)

NCT03930615

Conditions
Cytomegalovirus Infection, Cytomegalovirus Infections, DNA Virus Infections, +3 more
Locations
  • City of Hope National Medical Center ( Site 0158) Duarte, California, United States
  • University of California Davis Medical Center ( Site 0156) Sacramento, California, United States
  • University of Miami, Sylvester Comprehensive Cancer Center ( Site 0160) Miami, Florida, United States
  • Indiana Blood and Marrow Transplantation ( Site 0175) Indianapolis, Indiana, United States
View all 32 locations
View Trial Details
Completed

MK-8228 (Letermovir) in the Prevention of Human Cytomegalovirus (CMV) Infection and Disease in Adult Japanese Kidney Transplant Recipients (MK-8228-042)

NCT04129398

Conditions
Cytomegalovirus Disease, Cytomegalovirus Infection, Cytomegalovirus Infections, +4 more
Locations
  • Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital ( Site 0002) Nagoya, Aichi-ken, Japan
  • Sapporo City General Hospital ( Site 0004) Sapporo, Hokkaido, Japan
  • Osaka University Hospital ( Site 0003) Suita, Osaka, Japan
  • Tokyo Women's Medical University Hospital ( Site 0001) Tokyo, Japan
View Trial Details
Completed

CMV Antiviral Prevention Strategies in D+R-Liver Transplants ("CAPSIL")

NCT01552369

Conditions
Amino Acid Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cytomegalovirus Infection, +11 more
Locations
  • Ronald Reagan University of California Los Angeles Medical Center Los Angeles, California, United States
  • Emory Clinic - Transplant Center Atlanta, Georgia, United States
  • Mayo Clinic, Rochester - Infectious Diseases Rochester, Minnesota, United States
  • Mount Sinai School of Medicine - Medicine - Infectious Diseases New York, United States
View Trial Details
Completed

Study of CMX001 to Prevent/Control Cytomegalovirus Infection in R+ Hematopoietic Stem Cell Transplant Recipients

NCT00942305

Conditions
Cytomegalovirus Infection, Cytomegalovirus Infections, DNA Virus Infections, +3 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • Moores UCSD Cancer Center La Jolla, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • University of Colorado Denver Aurora, Colorado, United States
View all 26 locations
View Trial Details
Completed

Maribavir for Prevention of CMV After Stem Cell Transplants

NCT00223925

Conditions
Cytomegalovirus Infection, Cytomegalovirus Infections, DNA Virus Infections, +3 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Loyola University Maywood, Illinois, United States
  • Tufts-New England Medical Center Boston, Massachusetts, United States
View all 13 locations
View Trial Details
Completed

Safety, Reactogenicity, and Immunogenicity of Cytomegalovirus Vaccines mRNA-1647 and mRNA-1443 in Healthy Adults

NCT03382405

Conditions
Cytomegalovirus Infection, Cytomegalovirus Infections, DNA Virus Infections, +3 more
Locations
  • Research Centers of America Hollywood, Florida, United States
  • Advanced Clinical Research Meridian, Idaho, United States
  • Optimal Research Peoria, Illinois, United States
  • Johnson County Clinical Trials Lenexa, Kansas, United States
View Trial Details

Related conditions